Technical Analysis for GBIO - Generation Bio Co.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Fell Below 20 DMA | Bearish | 1.38% | |
Bollinger Band Squeeze | Range Contraction | 1.38% | |
Shooting Star Candlestick | Bearish | -5.96% | |
Lizard Bearish | Bearish Day Trade Setup | -5.96% | |
Bollinger Band Squeeze | Range Contraction | -5.96% | |
Doji - Bearish? | Reversal | -5.96% | |
20 DMA Support | Bullish | -7.53% | |
MACD Bullish Signal Line Cross | Bullish | -7.53% |
Alert | Time |
---|---|
Possible Inside Day | about 19 hours ago |
20 DMA Resistance | about 22 hours ago |
10 DMA Resistance | about 22 hours ago |
Rose Above 20 DMA | about 23 hours ago |
Rose Above 10 DMA | about 23 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 11/07/2024
Generation Bio Co. Description
Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company is designing therapies to provide targeted delivery of genetic payloads that include large and multiple genes across a broad array of tissues, and to be redosable for individualized and extended treatment throughout a patient’s life. The platform is designed to expand access to treatments for rare diseases and to address prevalent diseases through efficient, scalable manufacturing.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Emerging Technologies Molecular Biology Rare Diseases Gene Therapy Manufacturing Process Lipid Applied Genetics Gene Delivery
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.65 |
52 Week Low | 0.9898 |
Average Volume | 104,617 |
200-Day Moving Average | 2.75 |
50-Day Moving Average | 2.44 |
20-Day Moving Average | 2.31 |
10-Day Moving Average | 2.26 |
Average True Range | 0.18 |
RSI (14) | 44.44 |
ADX | 19.06 |
+DI | 13.24 |
-DI | 22.78 |
Chandelier Exit (Long, 3 ATRs) | 2.09 |
Chandelier Exit (Short, 3 ATRs) | 2.61 |
Upper Bollinger Bands | 2.49 |
Lower Bollinger Band | 2.12 |
Percent B (%b) | 0.24 |
BandWidth | 16.10 |
MACD Line | -0.06 |
MACD Signal Line | -0.06 |
MACD Histogram | 0.0009 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.44 | ||||
Resistance 3 (R3) | 2.45 | 2.39 | 2.40 | ||
Resistance 2 (R2) | 2.39 | 2.33 | 2.38 | 2.38 | |
Resistance 1 (R1) | 2.30 | 2.30 | 2.27 | 2.29 | 2.37 |
Pivot Point | 2.24 | 2.24 | 2.23 | 2.23 | 2.24 |
Support 1 (S1) | 2.15 | 2.18 | 2.12 | 2.14 | 2.05 |
Support 2 (S2) | 2.09 | 2.15 | 2.08 | 2.04 | |
Support 3 (S3) | 2.00 | 2.09 | 2.02 | ||
Support 4 (S4) | 1.99 |